Research finds cannabinoids increase anxiety through somatostatin neuron activity in mice — Evidence Review

Northwestern University researchers have identified a specific group of neurons in the central amygdala that mediate anxiety triggered by cannabinoid drugs under stress. Related studies generally support these findings, highlighting the complex, dose-dependent effects of cannabinoids on anxiety and the key role of somatostatin neurons. For further details, see the original source.

• The new study directly links somatostatin neuron activity in the central amygdala to cannabinoid-induced anxiety, which builds on previous research showing that somatostatin-expressing cells in various brain regions modulate anxiety behaviors, often in response to stress or drug exposure 1 2 5.
• Multiple related studies demonstrate that cannabinoids have biphasic (both anxiety-reducing and anxiety-inducing) effects depending on dose, receptor subtype, and neural circuits involved, with high doses or stressful contexts often shifting effects toward anxiety, consistent with the new findings 7 8 10 11.
• Prior research has implicated endocannabinoid signaling in stress and anxiety regulation across several brain areas, including the amygdala and nucleus accumbens, and has identified the importance of neural subpopulations like somatostatin and calretinin neurons in shaping anxiety responses 1 2 4.

Study Overview and Key Findings

The increasing use of cannabis and cannabinoid-based products has raised concerns about their potential to cause anxiety and other adverse effects, especially in stressful situations. Previous research has established that cannabinoids can have both calming and anxiety-provoking effects, but the underlying neural mechanisms have remained unclear. This study from Northwestern University addresses this gap by identifying a specific subset of neurons—somatostatin neurons in the central amygdala—that become hyperactive when cannabinoids are combined with stress, resulting in anxiety-related behaviors in mice.

The research is timely given the rising prevalence of cannabis use and associated emergency department visits for anxiety and panic. Importantly, the study not only elucidates a cellular pathway for cannabinoid-induced anxiety but also suggests these neurons could be a broader target for anxiety treatments.

Property	Value
Study Year	2023
Organization	Northwestern University Feinberg School of Medicine
Journal Name	Nature Communications
Authors	Dr. Sachin Patel, Farhana Yasmin, Saptarnab Naskar, Danyal Zaidi, Isaac Kandil, Michelle Kwon, Dr. Luis Rosas-Vidal
Population	Mice
Methods	Animal Study
Outcome	Anxiety-related behaviors, brain activity changes
Results	Cannabinoids increased anxiety via somatostatin neuron activity.

Literature Review: Related Studies

To place these findings in context, we searched the Consensus database (over 200 million papers) for relevant studies. The following search queries were used:

1. cannabis anxiety somatostatin neurons
2. cannabinoids brain activity anxiety
3. neurotransmitters cannabis anxiety effects

Literature Review Table

Topic	Key Findings
How do cannabinoids influence anxiety and brain circuits?	- Cannabinoids have biphasic effects on anxiety: low doses are anxiolytic, high doses are anxiogenic, mediated by CB1 receptor subtypes and neural circuits 7 8 10 11. - Amygdalar CB1 receptor availability is linked to THC-induced anxiety in humans 12.
What is the role of somatostatin neurons in anxiety and stress responses?	- Somatostatin-expressing neurons in both the amygdala and other regions modulate anxiety, with activation increasing anxiety and inhibition reducing it 1 2 5. - Growth hormone signaling in amygdala somatostatin neurons regulates anxiety and fear memory 5.
How do different cannabinoids (THC vs. CBD) and context affect anxiety outcomes?	- THC typically induces anxiety, especially at higher doses or under stress, while CBD tends to reduce anxiety by modulating limbic activity 6 9 11 12. - Effects are context- and dose-dependent, with environment and stress amplifying negative responses 7 8 10 11.
What are the implications for anxiety disorders and potential treatments?	- The endocannabinoid system is a promising but complex target for novel anxiolytic drugs, with mixed evidence regarding efficacy and safety for anxiety treatment 13 14. - Suppressing specific neural pathways (e.g., somatostatin neurons) may provide new therapeutic avenues 1 5.

---

How do cannabinoids influence anxiety and brain circuits?

The literature consistently shows that cannabinoids, particularly THC, have dose-dependent and context-sensitive effects on anxiety, mediated through CB1 receptors in key brain regions such as the amygdala. The new study aligns with these findings by identifying a direct pathway—via somatostatin neurons in the central amygdala—through which cannabinoids can drive anxiety, especially under stress.

• Both animal and human studies demonstrate biphasic effects of cannabinoids: low doses often reduce anxiety, while high doses or stressful situations increase it 7 8 10 11.
• CB1 receptor availability in the amygdala is correlated with the degree of THC-induced anxiety in humans 12.
• The amygdala and related circuits are repeatedly implicated as central sites for cannabinoid effects on emotional regulation 7 8 12.
• The new findings add a cellular mechanism (somatostatin neuron hyperactivity) that fits within this broader circuit model.

What is the role of somatostatin neurons in anxiety and stress responses?

Multiple studies highlight the importance of somatostatin-expressing neurons in anxiety regulation across brain regions, including the amygdala and zona incerta. The Northwestern study provides direct evidence that activation of these neurons is necessary for the anxiogenic effects of cannabinoids under stress.

• Activation of somatostatin neurons in the central amygdala or zona incerta increases anxiety, while inhibition has the opposite effect 1 5.
• Endocannabinoid signaling regulates the excitability and input balance of somatostatin neurons in stress contexts 2.
• Growth hormone signaling in amygdala somatostatin neurons modulates both anxiety and fear memory, indicating these cells' broader relevance to neuropsychiatric disorders 5.
• The new study's demonstration that silencing somatostatin neurons blocks cannabinoid-induced anxiety behaviors provides a direct mechanistic link 1 2 5.

How do different cannabinoids (THC vs. CBD) and context affect anxiety outcomes?

Evidence indicates that THC and CBD have divergent effects on anxiety, and that outcomes depend on both dose and situational context. This is consistent with the new study's finding that cannabinoids provoke anxiety mainly under stress and at higher doses.

• THC is associated with anxiety and panic, especially at high doses or in stressful environments, while CBD has been shown to reduce anxiety in both animals and humans 6 9 11 12.
• The effects of cannabinoids are context-dependent, with environmental stressors amplifying anxiogenic responses 8 10 11.
• The biphasic nature of cannabinoid effects is well-documented, with low doses sometimes being anxiolytic and high doses anxiogenic 7 10 11.
• The new research reinforces the need to consider both drug type and context in predicting anxiety outcomes from cannabinoid use.

What are the implications for anxiety disorders and potential treatments?

The complexity of cannabinoid effects on anxiety highlights both the therapeutic potential and the risks of targeting the endocannabinoid system for anxiety disorders. The identification of neural subpopulations like somatostatin neurons as key mediators opens new avenues for more targeted therapies.

• The endocannabinoid system is a promising target for novel anxiolytic drugs, but evidence for clinical efficacy remains limited and mixed 13 14.
• Suppressing overactive neural pathways (such as somatostatin neurons in the amygdala) could represent a more specific and potentially safer approach to reducing anxiety 1 5.
• Current clinical data suggest caution, as cannabinoid therapies—especially those based on THC—may increase anxiety in some individuals, particularly under stress or at high doses 11 14.
• High-quality human studies are needed to clarify benefits, risks, and mechanisms of cannabinoid-based interventions for anxiety 13 14.

Future Research Questions

While this study advances understanding of how cannabinoids can induce anxiety through specific neural circuits, many questions remain unanswered. Further research is needed to clarify the roles of different cannabinoids, the relevance of these findings to humans, and the potential for targeted interventions.

Research Question	Relevance
Do somatostatin neurons in the human amygdala mediate cannabis-induced anxiety?	Determining if the mechanism identified in mice also operates in humans is critical for translating these findings to clinical contexts 1 5 12.
How do different cannabinoids (THC, CBD) affect somatostatin neurons and anxiety?	Clarifying the distinct effects of THC and CBD on somatostatin neuron activity could guide safer therapeutic use and inform risk profiles 6 9 11 12.
Can targeting somatostatin neurons reduce anxiety in patients with cannabis-related side effects?	Exploring interventions that modulate somatostatin neuron activity could provide new treatments for cannabis-induced or general anxiety 1 5 13.
What are the long-term effects of cannabinoid-induced anxiety on brain circuits?	Long-term consequences of repeated cannabinoid-induced anxiety, especially in adolescents or chronic users, are not well understood 7 8 14.
How do individual differences (genetics, sex, stress history) modulate cannabinoid-anxiety responses?	Individual susceptibility to cannabinoid-induced anxiety may depend on genetics, sex, or prior stress, which could inform personalized risk assessments 5 11 14.